Catalyst Wire Dossier Catalyst Wire Dossier

Zytiga

abiraterone acetate · Janssen Biotech, Inc.
Drug timelines are a Plus or Pro feature.

70 regulatory and trial events tracked for Zytiga, covering 2011-04-28 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer [Phase 2]

See pricing